Alumis Inc. (ALMS)
NASDAQ: ALMS · Real-Time Price · USD
6.03
+0.18 (3.08%)
At close: Nov 6, 2026, 4:00 PM EST
6.10
+0.07 (1.16%)
After-hours: Nov 6, 2026, 7:39 PM EST
Alumis Market Cap
Alumis has a market cap or net worth of $780.49 million as of November 6, 2026. It is the 11,420th most valuable company in the world and the 2,389th biggest in the United States. Its market cap has increased by 64.12% in one year.
Market Cap
780.49M
Enterprise Value
314.63M
1-Year Change
64.12%
Global Rank
Country Rank
#2,389 United States
Category
ChartMarket Cap Chart
Since the IPO on June 28, 2024, Alumis's market cap has decreased from $901.92M to $780.49M, a decrease of -13.46%. That is a compound annual growth rate of -5.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 780.49M | -23.40% |
| Dec 31, 2025 | 1.02B | 138.26% |
| Dec 31, 2024 | 427.64M | -52.59% |
| Jun 28, 2024 | 901.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| City Therapeutics | 832.93M |
| Corvus Pharmaceuticals | 828.59M |
| Aktis Oncology | 809.82M |
| Ardelyx | 799.36M |
| Prime Medicine | 781.00M |
| Latigo Biotherapeutics | 770.40M |
| Arbutus Biopharma | 755.78M |
| Cullinan Therapeutics | 747.80M |